Finally, ultra-deep sequencing of PKD1 and PKD2 based on LR-PCR amplification (S9 Table) might be an option especially in mutation-negative patients with a clear ADPKD phenotype and negative family history to allow for detection of low-level mosaicism. This evidence concerns the gene PKD2 and autosomal dominant polycystic kidney disease.